An interventional study of Community-based Intervention in Well-being/Quality of Life and Mental Health, sponsored by National Healthcare Group Polyclinics. Recruiting at 1 site in Singapore. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by National Healthcare Group Polyclinics · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Psychological Well-Being with a site in Singapore — 5 open to participants now, 9 under way, none of them phase 3. Psychological Well-Being · Singapore.
Among the 24 studies in Psychological Well-Being with a site in Singapore, this one is the 6th largest by planned enrollment of the 18 interventional ones that give a count, is one of 3 that started in 2026, is one of 18 with no phase, and was the 22nd registered.
2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.
Browse Psychological Well-Being studies →5 of the 24 studies in Psychological Well-Being with a site in Singapore are open now. Recruiting first, the newest first:
National University Hospital, Singapore · Sites in Singapore
Ages 16+
Institute for Human Development and Potential (IHDP), Singapore · Sites in Singapore
Ages 40–60 · Women only · Healthy volunteers
Nanyang Technological University · Sites in Singapore
Ages 18–25 · Healthy volunteers
Nanyang Technological University · Sites in Singapore
Ages 21+ · Healthy volunteers
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.
This study: 55 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 300 is above the median of 110 across 1,808 interventional studies indexed under Psychological Well-Being.
Median enrollment 116 across the 18 interventional studies, 598 across the 6 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 24 have an industry lead sponsor. The 10 most frequent:
National Healthcare Group Polyclinics is the lead sponsor of 9 studies on the registry; 5 are open to participants now.
National Healthcare Group Polyclinics has 1 study filed under Psychological Well-Being — fewer than ten, so there is no comparison to draw.
1 of the studies in Psychological Well-Being with a site in Singapore that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05049499National University of SingaporeLong-term Academic and Psychosocial Impact of Child's Sleep: Parental Influences | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Psychological Well-Being with a site in Singapore, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is conducted to assess the effectiveness of a community intervention programme on improving well-being, levels of distress, and loneliness in older adults (aged 55 years old and above), who have symptoms of depression.
Social Service Agencies (SSAs) will conduct focal talks on well-being for the community. As part of the focal talks, the Public Health Questionnaire-9 (PHQ-9) will be conducted. Attendees with a PHQ-9 score of 1-9 will be invited to take part in the study. Up to 300 participants will be recruited and randomised into 2 arms: control arm (150 participants) and intervention arm (150 participants).
Participants in the intervention arm will undergo 8-week community intervention programme which includes 4 sessions on well-being and continuous follow-up with a Health Companion. Participants in the control arm will be offered to join a programme conducted by the SSAs 8 weeks after recruitment into the study. The programmes offered to the control group are independent of the study.
Study Procedures:
Control arm: Participants randomised into the control arm will not be offered any programmes for 8 weeks after their recruitment into the study. After 8 weeks, the SSAs will offer the participants an intervention programme that is independent of the study.
Intervention arm: Participant in the intervention arm will undergo 4 face-to-face, group psychoeducation sessions, conducted fortnightly over a period of 8 weeks. The sessions will teach the participants about well-being and share with them strategies to improve their well-being. Health Companions from the SSAs will conduct check-ins with the participants over the phone, and recommend some nearby activities for them.
Methods and assessments:
Questionnaires including the 6-item De Jong Gierveld Loneliness Scale, Warwick-Edinburgh Mental Wellbeing Scale, Patient Health Questionnaire-9, and Generalised Anxiety Disorder-7 at the baseline and endpoint for all participants.
Expected risks:
During the administration of the questionnaires, participants may feel uncomfortable or upset. Participants may choose to refuse to asnwer any of the questions, or take a break at any time during the questionnaire administration.
Participants in the intervention arm may feel discomfort, anxiousness or distress while undergoing the intervention programme. Participants may cease their enrolment in the study, or be encouraged to attend clinical follow-ups or reach out to the Social Service Agencies' Community Intervention Team (COMIT).
Safety Review Plan:
As this study does not involve any invasive procedures, the study team does not foresee any adverse events related to the study.
Data Quality Assurance:
The PI or study team member will review all data collection forms on an ongoing basis for data completeness, accuracy and protocol compliance, after every data collection timepoint.
Data entry and storage:
For hardcopy data, they will be stored in designated locked cabinet(s) or room(s) that are accessible to authorized study personnel only. For electronic data, they will be stored on in a secured computer that is password protected. The databases will not contain subject identifiers and the data linking subject identifiers and the subject identification codes will be stored separately.
Sample size calculation:
An a priori power analysis was conducted to determine the required sample size for detecting a statistically significant difference in the primary outcome, the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), between the intervention and control arms. The effect size based on standardised mean differences (SMD) for this calculation was informed by a comprehensive systematic review by Blodgett et al. (2022), which reported a medium to large range of SMD from 0.38 to 0.72 for selected themes and subthemes of intervention across studies. To ensure the study is adequately powered for a conservative estimate, the smallest effect size from this range, d = 0.38, was used for the calculation. The power analysis was performed for a two-tailed independent samples t-test using the pwr package in R, with a standard significance level (α) of 0.05 and a desired power (1-β) of 0.80. The results indicated that a minimum of 110 participants per group is required. To account for a potential 20% attrition rate, the minimum recruitment target is about 130 participants per arm. The study team rounded up the number to 150 participants per arm, with a total of 300 participants to be recruited.
Statistical and analytical plans:
Data will be analysed using SPSS/Stata/R. Normality of the data will be checked using the Kolmogorov-Smirnov test. Differences between variables will be tested by t-test and Mann-Whitney U test for normal and non-normal continuous variables respectively and chi-square test or Fisher-exact test for categorical variables. Associations with the improvement in scores will be analysed via multivariable regressions. P value \<0.05 will indicate statistical significance.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Waitlist Control
Community-based Intervention
Behavioral: Community-based Intervention
Psychoeducation Programme
Well-being
Measured by Warwick-Edinburgh Mental Well-being Scale (WEMWBS) Minimum score: 7 Maximum score: 35 Higher scores indicate higher positive mental well-being (Better outcome).
Time frame: 8 weeks
Depressive symptoms
Measured by Patient Health Questionnaire-9 (PHQ-9) Minimum score: 0 Maximum score: 27 Higher scores represent higher severity of the symptoms of depression (worse outcome). Specifically, scores of 0-4 represent none to minimal depression severity; scores of 5-9 represent mild depression severity; scores of 10-14 represent moderate depression; scores of 15-19 represent moderately severe depression; scores of 20-27 represent severe depression.
Time frame: 8 weeks
Anxiety symptoms
Measured by Generalised Anxiety Disorder-7 (GAD-7) Minimum score: 0 Maximum score: 21 Higher scores represent higher severity of anxiety symptoms (worse outcome). Specifically, scores of 0-4 represent minimal anxiety; scores of 5-9 represent mild anxiety; scores of 10-14 represent moderate anxiety; scores of 15-21 represent severe anxiety.
Time frame: 8 weeks
Loneliness
Measured by De Jong Gierveld Loneliness Scale Minimum score: 0 Maximum score: 6 Higher scores represent higher severity of loneliness (worse outcome). Specifically, scores of 0-2 represent low levels of loneliness; scores of 3-4 represent moderate levels of loneliness; scores of 5-6 represent intense/severe levels of loneliness.
Time frame: 8 weeks
Acceptability, feasibility and satisfaction of the intervention
Measured through qualitative interviews, where qualitative data will be analysed qualitatively to understand participants' acceptability and satisfaction to the intervention programme, and the feasibility of the intervention programme.
Time frame: 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Dec 2027, 20 months after the start.
Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 20 months is above that.
Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.
Start moved once since we started tracking on Sep 25, 2026: Mar 2026 → Apr 2026, on Nov 17, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Healthcare Group Polyclinics